ZAGREB, April 15 (Hina) - The Croatian pharmaceutical company Pliva bought the British company Mixis genetics Ltd. for US$3.3 million, the Pliva management reported on Thursday. By this, Pliva has become the owner of several patents
of the most up-to-date technology in the field of the biological variety production. According to the Pliva Board president, Zeljko Covic, technologies of the British company complement Pliva's achievements. At the moment, Pliva is developing a series of new processes in the field of biological variety.(hina) it jn/ms
ZAGREB, April 15 (Hina) - The Croatian pharmaceutical company Pliva
bought the British company Mixis genetics Ltd. for US$3.3 million,
the Pliva management reported on Thursday.
By this, Pliva has become the owner of several patents of the most
up-to-date technology in the field of the biological variety
production.
According to the Pliva Board president, Zeljko Covic, technologies
of the British company complement Pliva's achievements.
At the moment, Pliva is developing a series of new processes in the
field of biological variety.
(hina) it jn/ms